Lachlan Hanbury Brown
Stock Analyst at William Blair
(0.20)
# 4,653
Out of 5,078 analysts
146
Total ratings
36.3%
Success rate
-9.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lachlan Hanbury Brown
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HROW Harrow | Reiterated: Buy | n/a | $28.44 | - | 22 | Oct 5, 2026 | |
| SRZN Surrozen | Reiterated: Buy | n/a | $25.48 | - | 4 | Oct 2, 2026 | |
| TSX: EPRX Eupraxia Pharmaceuticals Inc. | Reiterated: Buy | n/a | $9.57 | - | 8 | Sep 30, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | n/a | $9.81 | - | 3 | Sep 30, 2026 | |
| QURE uniQure | Reiterated: Buy | n/a | $22.43 | - | 1 | Sep 29, 2026 | |
| SRPT Sarepta Therapeutics | Reiterated: Hold | n/a | $17.73 | - | 1 | Sep 28, 2026 | |
| OCUL Ocular Therapeutix | Reiterated: Buy | n/a | $6.50 | - | 20 | Sep 25, 2026 | |
| SPRY ARS Pharmaceuticals | Reiterated: Buy | n/a | $4.03 | - | 28 | Aug 14, 2026 | |
| LENZ LENZ Therapeutics | Reiterated: Buy | n/a | $3.16 | - | 20 | Aug 12, 2026 | |
| TARS Tarsus Pharmaceuticals | Reiterated: Buy | n/a | $68.20 | - | 14 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.87 | - | 13 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $22.37 | - | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.92 | - | 2 | Mar 20, 2026 |
Harrow
Oct 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $28.44
Upside: -
Surrozen
Oct 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $25.48
Upside: -
Eupraxia Pharmaceuticals Inc.
Sep 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.57
Upside: -
Zevra Therapeutics
Sep 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.81
Upside: -
uniQure
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.43
Upside: -
Sarepta Therapeutics
Sep 28, 2026
Reiterated: Hold
Price Target: n/a
Current: $17.73
Upside: -
Ocular Therapeutix
Sep 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $6.50
Upside: -
ARS Pharmaceuticals
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.03
Upside: -
LENZ Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.16
Upside: -
Tarsus Pharmaceuticals
Aug 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $68.20
Upside: -
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.87
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.37
Upside: -
Mar 20, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.92
Upside: -